Company Probi AB

Equities

PROB

SE0001280355

Pharmaceuticals

Real-time Estimate Cboe Europe 04:05:22 2024-03-19 am EDT 5-day change 1st Jan Change
209 SEK -1.42% Intraday chart for Probi AB -9.79% +4.43%

Business Summary

Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company's activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.

Sales per Business

SEK in Million2021Weight2022Weight Delta
Probiotics
98.5 %
643 97.7 % 609 98.5 % -5.23%
Royalties
1.5 %
15 2.3 % 9 1.5 % -40.70%

Sales per region

SEK in Million2021Weight2022Weight Delta
United States
72.5 %
478 72.6 % 448 72.5 % -6.20%
EMEA, excluding Sweden
11.9 %
85 12.9 % 74 11.9 % -12.86%
Asia Pacific
8.8 %
49 7.5 % 54 8.8 % +9.51%
Sweden
5.8 %
39 6.0 % 36 5.8 % -9.34%
Americas excluding United States
1.0 %
7 1.0 % 6 1.0 % -6.31%

Managers

Managers TitleAgeSince
Chief Executive Officer - 22-03-31
Director of Finance/CFO 58 Oct. 31
Chief Operating Officer 54 23-02-28
Chief Tech/Sci/R&D Officer 54 07-12-31
Director/Board Member 44 13-12-31
Human Resources Officer 41 19-12-31
Sales & Marketing 56 19-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 53 20-05-12
Chairman 60 15-03-31
Director/Board Member 62 17-05-03
Director/Board Member 44 13-12-31
Director/Board Member 66 18-05-01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,394,125 3,175,771 ( 27.87 %) 0 27.87 %

Shareholders

NameEquities%Valuation
SYMRISE AG
69.42 %
7,909,256 69.42 % 152 M kr
Wiborg Kapitalförvaltning AB
11.99 %
1,365,656 11.99 % 26 M kr
Tanglin Asset Management AB
3.920 %
446,664 3.920 % 9 M kr
Swedbank Robur Fonder AB
1.814 %
206,737 1.814 % 4 M kr
Livförsäkringsbolaget Skandia, ömsesidigt
1.321 %
150,507 1.321 % 3 M kr
SEB Investment Management AB (Denmark)
0.8515 %
97,023 0.8515 % 2 M kr
Sjätte AP-fonden
0.7087 %
80,754 0.7087 % 2 M kr
Nordea Investment Management AB (Finland)
0.5902 %
67,244 0.5902 % 1 M kr
Danske Capital AB
0.4418 %
50,343 0.4418 % 968 186 kr
44,948 0.3945 % 864 430 kr

Company contact information

Probi AB

Ideongatan 1A

223 70, Lund

+46 4 62 86 89 20

http://www.probi.se
address Probi AB(PROB)

Group companies

NameCategory and Sector
Biotechnology